Wealth Alliance’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Wealth Alliance's VRTX Position: Q2 2026 in Review
Wealth Alliance reduced its Vertex Pharmaceuticals (VRTX) stake by 7.8% in Q2 2026, selling an estimated $53.2K and leaving 1,426 shares worth $708K. The position accounts for 0.06% of the portfolio, ranked #243.
Wealth Alliance first reported a position in VRTX in Q4 2023 and has held it in 5 quarters since. The position peaked at $710K in Q4 2025. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Wealth Alliance held 1,426 shares of Vertex Pharmaceuticals worth $708K as of Q2 2026.
- Wealth Alliance sold 120 Vertex Pharmaceuticals shares in Q2 2026, an estimated $53.2K.
- Vertex Pharmaceuticals made up 0.06% of Wealth Alliance's portfolio in Q2 2026, its #243 holding.
- Wealth Alliance first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
- Wealth Alliance's Vertex Pharmaceuticals position peaked at $710K in Q4 2025.
- 1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Wealth Alliance's 13F filing for Q2 2026, filed 11 Aug 2026.